Twenty-one years after its approval by the FDA, mifepristone could—but probably won’t— revolutionize a post-Roe world. By Cynthia Koons

The CEO Playbook to Navigating Trump
18:56

The Dawn of Music’s AI Era
32:43

The Startup Making Human Embryos With AI-Assisted Robots
37:40